Precigen announces departure of chief financial officer

Germantown, md., march 30, 2021 /prnewswire/ -- precigen, inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that by mutual agreement rick sterling is stepping down from his position as chief financial officer effective april 2, 2021.
PGEN Ratings Summary
PGEN Quant Ranking